Revalia Bio is building the world's first integrated Human Data Stack^TM to power a new category of Phase 0 Human Trials. Revalia's Phase 0 Human Trial platform supports agile biomedical innovation by allowing developers to ask and answer questions that would be impossible in traditional Clinical Trials or Preclinical models. The key to the platform is Revalia's 'Human Organ Data Layer' made possible by a unique network of partnerships that support organ donation for research when the organs are deemed unsuitable for clinical transplant. The Revalia team brings those organs back to life on proprietary perfusion technology to create a Rosetta Stone for human data that can contextualize and integrate all other data sources from patient medical records to the behavior of cells in a petri dish. Revalia provides access to its Phase 0 Human Trials through a software-enabled, Platform as a Service model that allows biomedical developers to focus on innovation and not on building and maintaining human data infrastructure.